1/13
05:26 am
autl
Autolus Therapeutics (AUTL) Valuation Check After Revenue Guidance And AUCATZYL UK And EU Approvals [Yahoo! Finance]
High
Report
Autolus Therapeutics (AUTL) Valuation Check After Revenue Guidance And AUCATZYL UK And EU Approvals [Yahoo! Finance]
1/12
10:37 am
autl
Autolus Therapeutics (NASDAQ:AUTL) had its price target lowered by analysts at Needham & Company LLC from $11.00 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
Autolus Therapeutics (NASDAQ:AUTL) had its price target lowered by analysts at Needham & Company LLC from $11.00 to $10.00. They now have a "buy" rating on the stock.
1/12
07:20 am
autl
Autolus Therapeutics Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Net Product Revenue, Pipeline Advancements and Outlook for 2026 [Yahoo! Finance]
High
Report
Autolus Therapeutics Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Net Product Revenue, Pipeline Advancements and Outlook for 2026 [Yahoo! Finance]
1/12
07:00 am
autl
Autolus Therapeutics Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Net Product Revenue, Pipeline Advancements and Outlook for 2026
High
Report
Autolus Therapeutics Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Net Product Revenue, Pipeline Advancements and Outlook for 2026
1/6
09:27 am
autl
Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell ShuttleTM Platform [Yahoo! Finance]
Medium
Report
Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell ShuttleTM Platform [Yahoo! Finance]
1/6
09:00 am
autl
Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell ShuttleTM Platform
Medium
Report
Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell ShuttleTM Platform
1/6
09:00 am
autl
Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell Shuttle™ Platform
Medium
Report
Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell Shuttle™ Platform
12/30
08:12 am
autl
Needham ups Autolus target, names top pick for 2026 [Yahoo! Finance]
Medium
Report
Needham ups Autolus target, names top pick for 2026 [Yahoo! Finance]
12/29
08:02 am
autl
Autolus Therapeutics (NASDAQ:AUTL) had its price target raised by analysts at Needham & Company LLC from $10.00 to $11.00. They now have a "buy" rating on the stock.
High
Report
Autolus Therapeutics (NASDAQ:AUTL) had its price target raised by analysts at Needham & Company LLC from $10.00 to $11.00. They now have a "buy" rating on the stock.
12/27
08:02 am
autl
Is Autolus Therapeutics plc (AUTL) The Best Get Rich Fast Stocks to Buy Right Now? [Yahoo! Finance]
High
Report
Is Autolus Therapeutics plc (AUTL) The Best Get Rich Fast Stocks to Buy Right Now? [Yahoo! Finance]
12/19
07:44 am
autl
Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030
Medium
Report
Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030
12/12
08:06 am
autl
Autolus Therapeutics (NASDAQ:AUTL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
Low
Report
Autolus Therapeutics (NASDAQ:AUTL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
12/8
04:05 pm
autl
Autolus Therapeutics Presents Updated Clinical Data from the CARLYSLE Trial in Patients with Severe Refractory Systemic Lupus Erythematosus at the American Society of Hematology (ASH) Annual Meeting 2025
Medium
Report
Autolus Therapeutics Presents Updated Clinical Data from the CARLYSLE Trial in Patients with Severe Refractory Systemic Lupus Erythematosus at the American Society of Hematology (ASH) Annual Meeting 2025
12/8
08:35 am
autl
Autolus Therapeutics Presents Initial Clinical Data in Pediatric r/r B-ALL Patients and Other Oncology Data at the American Society of Hematology (ASH) Annual Meeting 2025
Low
Report
Autolus Therapeutics Presents Initial Clinical Data in Pediatric r/r B-ALL Patients and Other Oncology Data at the American Society of Hematology (ASH) Annual Meeting 2025
12/1
07:13 am
autl
Autolus Therapeutics Appoints Ryan Richardson to Board of Directors [Yahoo! Finance]
Low
Report
Autolus Therapeutics Appoints Ryan Richardson to Board of Directors [Yahoo! Finance]
12/1
07:00 am
autl
Autolus Therapeutics Appoints Ryan Richardson to Board of Directors
Low
Report
Autolus Therapeutics Appoints Ryan Richardson to Board of Directors
11/25
04:00 am
autl
NICE Recommends AUCATZYL® (obecabtagene autoleucel) as a Treatment Option for Adult Patients (=26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)¹
High
Report
NICE Recommends AUCATZYL® (obecabtagene autoleucel) as a Treatment Option for Adult Patients (=26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)¹
11/15
07:05 pm
autl
Autolus Therapeutics plc (NASDAQ:AUTL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]
Medium
Report
Autolus Therapeutics plc (NASDAQ:AUTL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]
11/14
10:32 am
autl
Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline [Seeking Alpha]
Low
Report
Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline [Seeking Alpha]
11/12
04:32 pm
autl
Autolus Therapeutics PLC (AUTL) Q3 2025 Earnings Call Highlights: Navigating Challenges and ... [Yahoo! Finance]
Medium
Report
Autolus Therapeutics PLC (AUTL) Q3 2025 Earnings Call Highlights: Navigating Challenges and ... [Yahoo! Finance]
11/12
03:12 pm
autl
Autolus Therapeutics plc (AUTL) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Autolus Therapeutics plc (AUTL) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/12
08:21 am
autl
Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates [Yahoo! Finance]
Neutral
Report
Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates [Yahoo! Finance]
11/12
07:06 am
autl
Autolus Therapeutics GAAP EPS of -$0.30 misses by $0.08, revenue of $21.14M misses by $0.17M [Seeking Alpha]
Low
Report
Autolus Therapeutics GAAP EPS of -$0.30 misses by $0.08, revenue of $21.14M misses by $0.17M [Seeking Alpha]
11/12
07:00 am
autl
Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
Medium
Report
Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
11/11
08:00 am
autl
Santa Ana Bio Announces the Appointment of Mike Bonney as Chair of the Board
Medium
Report
Santa Ana Bio Announces the Appointment of Mike Bonney as Chair of the Board